COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies

• Nir Eyal,
• Arthur Caplan,
• Stanley Plotkin

Affiliations

Nir Eyal

Rutgers University

Arthur Caplan

Grossman School of Medicine, New York University Langone

Stanley Plotkin

University of Pennsylvania. Vaxconsult